Targeted Alpha Therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617
PSMA-617 is a small molecule targeting prostate-specific membrane antigen. In this work we estimate the radiation dosimetry for this ligand labeled with the alpha-emitter 213Bi.
KRATOCHWIL Clemens;
SCHMIDT K.;
BRUCHERTSEIFER Frank;
AFSHAR-OROMIEH Ali;
MORGENSTERN Alfred;
HABERKORN Uwe;
GIESEL Frederik;
2017-10-25
SPRINGER
JRC106723
1619-7070,
https://link.springer.com/journal/259/44/2/suppl/page/1,
https://publications.jrc.ec.europa.eu/repository/handle/JRC106723,
Additional supporting files
| File name | Description | File type | |
|---|
